Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
AHA's role during COVID-19 pandemic | Risk of death from stroke drops 24% | A new warning for heart patients
Thursday, March 19, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Top Stories

Making an impact: AHA outlines its role during COVID-19 pandemic

The American Heart Association (AHA) has shared a detailed account of its role as the world continues to fight against the spread of the new coronavirus.

READ MORE >
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Share on Twitter Share on Facebook Share on Linkedin

Making an impact: AHA outlines its role during COVID-19 pandemic

Share on Twitter Share on Facebook Share on Linkedin
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
The American Heart Association (AHA) has shared a detailed account of its role as the world continues to fight against the spread of the new coronavirus.
READ MORE >

Risk of death from stroke drops 24%

The primary reason behind this change is believed to be significant improvements in how healthcare providers care for stroke patients. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Risk of death from stroke drops 24%

Share on Twitter Share on Facebook Share on Linkedin
The primary reason behind this change is believed to be significant improvements in how healthcare providers care for stroke patients. 
READ MORE >

A new warning for heart patients as COVID-19 continues to spread

The British Heart Foundation (BHF) has published a statement warning patients with certain medical conditions, including cardiovascular diseases, to be “extra vigilant” as the new coronavirus continues to spread.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

A new warning for heart patients as COVID-19 continues to spread

Share on Twitter Share on Facebook Share on Linkedin
The British Heart Foundation (BHF) has published a statement warning patients with certain medical conditions, including cardiovascular diseases, to be “extra vigilant” as the new coronavirus continues to spread.
READ MORE >

HF patients with type 2 diabetes can safely be treated with liraglutide

Liraglutide, a common medication used to treat type 2 diabetes (T2D), is safe to use for heart failure (HF) patients, according to new findings published in the Journal of the American College of Cardiology.

READ MORE >
Diabetes
Share on Twitter Share on Facebook Share on Linkedin

HF patients with type 2 diabetes can safely be treated with liraglutide

Share on Twitter Share on Facebook Share on Linkedin
Diabetes
Liraglutide, a common medication used to treat type 2 diabetes (T2D), is safe to use for heart failure (HF) patients, according to new findings published in the Journal of the American College of Cardiology.
READ MORE >

In Case You Missed It

Patients with COVID-19 should keep taking key CVD medications

Patients with cardiovascular disease should continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) as prescribed if they are diagnosed with the new coronavirus (COVID-19), according to a joint statement from three medical societies. 

READ MORE >
coronavirus_2.jpg
Share on Twitter Share on Facebook Share on Linkedin

Patients with COVID-19 should keep taking key CVD medications

Share on Twitter Share on Facebook Share on Linkedin
coronavirus_2.jpg
Patients with cardiovascular disease should continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) as prescribed if they are diagnosed with the new coronavirus (COVID-19), according to a joint statement from three medical societies. 
READ MORE >

FDA updates warnings for cigarette packaging, advertisements—compliance required by June 2021

The FDA has published new requirements for the health warnings featured on cigarette packages and in cigarette advertisements.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA updates warnings for cigarette packaging, advertisements—compliance required by June 2021

Share on Twitter Share on Facebook Share on Linkedin
The FDA has published new requirements for the health warnings featured on cigarette packages and in cigarette advertisements.
READ MORE >

E-cigarette interferes with user’s implantable cardiac device, creating potential for ‘fatal consequences’

A patient’s e-cigarette interfered with their implantable cardioverter-defibrillator (ICD) and prevented the device from properly functioning, according to a new analysis published in HeartRhythm Case Reports.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

E-cigarette interferes with user’s implantable cardiac device, creating potential for ‘fatal consequences’

Share on Twitter Share on Facebook Share on Linkedin
A patient’s e-cigarette interfered with their implantable cardioverter-defibrillator (ICD) and prevented the device from properly functioning, according to a new analysis published in HeartRhythm Case Reports.
READ MORE >

From the Magazine

New Take on Transplant: Reconsidering Hepatitis C-infected Hearts for Donation

As many as 700 hearts from donors with hepatitis C are discarded each year in the U.S. New research suggests at least some of these organs may be suitable for transplant.

READ MORE >
Tom Giangiulio
Share on Twitter Share on Facebook Share on Linkedin

New Take on Transplant: Reconsidering Hepatitis C-infected Hearts for Donation

Share on Twitter Share on Facebook Share on Linkedin
Tom Giangiulio
As many as 700 hearts from donors with hepatitis C are discarded each year in the U.S. New research suggests at least some of these organs may be suitable for transplant.
READ MORE >

In Other News

Radiology practices should turn to CT exams to boost colorectal cancer screening rates

A number of patients recommended for CRC screening say they haven't undergone the exam, but have received a computed tomography scan. Researchers believe radiologists should jump on this fact.

READ MORE >
Waiting room
Share on Twitter Share on Facebook Share on Linkedin

Radiology practices should turn to CT exams to boost colorectal cancer screening rates

Share on Twitter Share on Facebook Share on Linkedin
Waiting room
A number of patients recommended for CRC screening say they haven't undergone the exam, but have received a computed tomography scan. Researchers believe radiologists should jump on this fact.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme